Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.63 |
| ▸ | NAALAD2 | Q9Y3Q0 | 5/20 | 0.63 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.63 |
| ▸ | GGH | Q92820 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL911011 | 1.00 | FOLH1 (0.63) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL73336 | 1.00 | FOLH1 (0.63) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Hydrogen Sulfide SCHEMBL27842653 | 0.98 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Ammonia Solution, Strong SCHEMBL4947922 | 0.98 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Sarcosine SCHEMBL28423014 | 0.89 | FOLH1 (0.52) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Methacrylic Acid SCHEMBL29289351 | 0.89 | FOLH1 (0.52) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| D-Glutamate SCHEMBL28443756 | 0.89 | GRM8 (0.62) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Acrylic Acid SCHEMBL28279497 | 0.89 | FOLH1 (0.52) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL12019171 | 0.88 | FOLH1 (0.48) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL27653325 | 0.86 | FOLH1 (0.49) | FOLH1NAALAD2RIMKLAGGHCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3452126-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3452125-B1 | CUSTOMIZABLE ANCHORAGE DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-07-16 | — | — | EP | claimed |
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | THE GENERAL HOSPITAL CORPORATION (US) | 2024-10-31 | — | — | US | claimed |
| WO-2023122430-A1 | COATING COMPOSITIONS FOR USE IN CREPED PAPER PRODUCT MANUFACTURING AND METHODS FOR PRODUCING THE SAME | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2023-06-29 | — | — | WO | claimed |
| EP-3452122-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2023-03-22 | — | — | EP | claimed |
| EP-3636222-B1 | SYSTEMS FOR MASTOPEXY | TEPHA INC (US) | 2022-04-13 | — | — | EP | claimed |
| EP-3507335-B1 | POLYMER COATINGS | COMMW SCIENT IND RES ORG (AU) | 2022-03-30 | — | — | EP | claimed |
| EP-3019854-B1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | MASSACHUSETTS GEN HOSPITAL (US) | 2021-01-06 | — | — | EP | claimed |
| EP-1372618-B1 | COLLOIDAL SUSPENSION OF NANOPARTICLES BASED ON AN AMPHIPHILIC COPOLYMER | FLAMEL TECH SA (FR) | 2012-12-05 | — | — | EP | claimed |
| JP-2008522811-A | — | — | 2008-07-03 | — | — | JP | claimed |
| EP-1843841-A1 | CATALYST AND METHOD FOR CONVERTING LOW MOLECULAR WEIGHT PARAFFINIC HYDROCARBONS INTO ALKENES | HRD Corp (US) | 2007-10-17 | — | — | EP | claimed |
| EP-1322411-B1 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR CARRYING ACTIVE PRINCIPLES AND THEIR MODE OF PREPARATION | FLAMEL TECH SA (FR) | 2007-01-17 | — | — | EP | claimed |
| US-20060135838-A1 | Catalyst and method for converting low molecular weight paraffinic hydrocarbons into alkenes | HRD CORP. | 2006-06-22 | — | — | US | claimed |
| WO-2006063230-A1 | CATALYST AND METHOD FOR CONVERTING LOW MOLECULAR WEIGHT PARAFFINIC HYDROCARBONS INTO ALKENES | HRD CORP. (US) | 2006-06-15 | — | — | WO | claimed |
| WO-2005104836-A2 | DROSOPHILA MODELS FOR DISEASES AFFECTING LEARNING AND MEMORY | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2005-11-10 | — | — | WO | claimed |
| EP-1478283-A2 | EXPANDABLE FASTENER WITH COMPRESSIVE GRIPS | Yeung, Jeffrey E. (US) | 2004-11-24 | — | — | EP | claimed |
| WO-2003071962-A2 | EXPANDABLE FASTENER WITH COMPRESSIVE GRIPS | YEUNG JEFFREY E (US) | 2003-09-04 | — | — | WO | claimed |
| EP-0705094-B1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PROD CO (US) | 2000-05-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | PPOX, HMOX2, HMOX1 | FOLH1 1359/4885NAALAD2 1900/4885RIMKLA 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.